Mark T. Fleming, MD, Talks Use of 18F-rhPSMA-7.3 for PET/CT in Recurrent Prostate Cancer
May 19, 2022

Mark T. Fleming, MD, spoke about how use of 18F-rhPSMA-7.3 for PET/CT scans in patients with recurrent prostate cancer bests conventional imaging.

Olaparib Reduced Pain and Yielded Better-Preserved HRQOL in Metastatic CRPC
May 19, 2022

Results from a phase 3 trial indicated that olaparib yielded better-preserved health-related quality of life and reduced pain burden vs the control for patients with homologous recombination repair gene–altered metastatic castration-resistant prostate cancer who progressed following a prior next-generation hormonal drug.

Black Women With Early HR+ Breast Cancer Have Shorter RFS and OS Vs White Women
May 19, 2022

Findings from a post-hoc analysis identified disparities in Black patients with early hormone receptor–positive breast cancer that could not be explained by early discontinuation of endocrine therapy, clinicopathologic characteristics, insurance coverage, or neighborhood deprivation index.

Transplant-Ineligible Multiple Myeloma: The SWOG0777 Study
May 19, 2022

Nisha Joseph, MD, presents the case of a 78-year-old man with transplant-ineligible multiple myeloma and discusses treatment strategy.

Defining High-Risk Multiple Myeloma
May 19, 2022

Experts discuss how they define frail and high-risk patients with multiple myeloma and their treatment approaches for these patient populations.

Earlier MRI Screenings Could Significantly Cut Breast Cancer Mortality for Certain Pathogenic Variants
May 19, 2022

Breast cancer mortality could be reduced by half for patients with ATM, CHEK2, and PALB2 pathogenic variants who undergo annual MRI screenings between the ages of 30 to 35 years and annual MRI screenings and mammography for those 40 or older.

GALAXY: DFS by Stage and ACT Receipt in ctDNA-Positive Patients
May 19, 2022

Stacy A. Cohen, MD, and Mark Lewis, MD, discuss how DFS correlates with stage and adjuvant chemotherapy receipt in patients who are ctDNA-positive.

Choosing Therapies for Patients with Advanced Renal Cell Carcinoma
May 19, 2022

A physician explains why he doesn’t believe there is a “typical” patient and why advanced RCC therapies must be tailored to each case.

GALAXY: DFS by ctDNA Status at Weeks 4 and 12 Post Surgery
May 19, 2022

GI oncologists discuss DFS data from the dynamics analysis cohort of the GALAXY study.

Perspectives on COVID-19 Prophylaxis and Vaccination
May 19, 2022

To close the discussion, panelists reflect on their practices’ guidance on long-acting antibody prophylaxis and vaccination against COVID-19 for patients with graft-versus-host-disease (GVHD).